Bulge Bracket IBD Analyst Program vs Small Cap Investment Fund Analyst

Mulling over two potential offers and don't really know which would be better from a career perspective.

Offer A: Second year analyst on a BB Analyst Training Program. I have been told that I will most likely be placed in FIG as I have previous experience in this area.

Offer B: Analyst in a small cap (c. $3bn AUM) investment fund focused exclusively on the insurance sector.

I feel that FIG IBD would most likely mean my exit opportunities would be Offer B type funds anyway, however I think the BB brand name could provide more flexibility down the road.

12 Comments
 

Could you elaborate on why?

I eventually want to be on the buy side so I thought the small cap fund would be a better place to start?

 

It's more that from what people say here the BB offer would give me more options down the road and provide a pedigree that a relatively small fund (sub $5bn), albeit quite well known in its industry, wouldn't necessarily be able to.

For example I eventually want to work in TMT in corporate development or another strategic managerial role.

I'm also interested in tech focused PE/VC as well.

I realise my chances are pretty thin with both offers but am I more likely to achieve this goal working in:

BB FIG (multiple products - M&A, LevFin, ECM, etc)

Buy side M&A insurance focused investment fund?

 

Risk is that 3 years down the line I am stuck in an Associate position, struggling to get on the buy side and regretting the fact I did not taking the Insurance opportunity.

I'll have almost 4 years post grad experience (at a Big 4 firm) by the time I join as a 2nd year analyst so I'll likely have almost 6 years (all of which would have been in FIG) experience by the time I try looking at PE/HF/Investment Managers. Couple that with trying to get a transfer and that probably adds another year on so 7. Would I still be marketable to a non FIG buy-side fund at this stage?

 

Quaerat assumenda nulla et natus placeat. Similique aut in placeat autem omnis aspernatur pariatur. Aut qui distinctio et fugiat qui. Occaecati quis occaecati molestias non omnis maxime. Rerum expedita id autem dicta sunt aspernatur ipsum. Optio voluptatem et maxime illum et impedit aperiam.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.3%
  • JPMorgan No 97.7%
  • Goldman Sachs 02 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (44) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”